Synlogic, Inc. (SYBX) Financials
SYBX Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 66.3 million | 22.9 million |
2023-06-30 | 79.3 million | 24.5 million |
2023-03-31 | 93.4 million | 24.7 million |
2022-12-31 | 110.9 million | 28.3 million |
SYBX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -13.0 million | 640000 |
2023-06-30 | -11.7 million | 645000 |
2023-03-31 | -21.6 million | 718000 |
2022-12-31 | -12.4 million | 878000 |
SYBX Net Income
No data available :(
SYBX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 33.4 million | - | 18.2 million |
2023-06-30 | 46.3 million | - | 19.2 million |
2023-03-31 | 57.4 million | - | 19.3 million |
2022-12-31 | 77.6 million | - | 20.3 million |
SYBX Shares Outstanding
SYBX Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | - | 9.6 million | 3.4 million | - |
2023-06-30 | 43000 | 11.8 million | 3.9 million | - |
2023-03-31 | 143000 | 12.5 million | 4.0 million | - |
2022-12-31 | 43000 | 13.6 million | 3.8 million | - |
SYBX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 393000 | 1.3 million |
2023-06-30 | 35000 | 1.4 million |
2023-03-31 | 174000 | 1.4 million |
2022-12-31 | 106000 | 1.4 million |
SYBX
Price: $1.84
52 week price:
Earnings Per Share: -8.81 USD
P/E Ratio: -0.14
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 107155
Ebitda: -10.6 millionMarket Capitalization: 20.7 million